Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

By | March 2, 2021
Researchers have developed small proteins from sequences in SARS-CoV-2’s RBD that bind to ACE2. These were as effective in binding to neutralizing antibodies as larger RBD proteins.